[go: up one dir, main page]

CL2004001009A1 - COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS - Google Patents

COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS

Info

Publication number
CL2004001009A1
CL2004001009A1 CL200401009A CL2004001009A CL2004001009A1 CL 2004001009 A1 CL2004001009 A1 CL 2004001009A1 CL 200401009 A CL200401009 A CL 200401009A CL 2004001009 A CL2004001009 A CL 2004001009A CL 2004001009 A1 CL2004001009 A1 CL 2004001009A1
Authority
CL
Chile
Prior art keywords
macrolids
profilaxis
replaced
members
procedure
Prior art date
Application number
CL200401009A
Other languages
Spanish (es)
Inventor
John Michael Berge
Andrew Keith Forrest
Richard Lewis Jarvest
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CL2004001009A1 publication Critical patent/CL2004001009A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL200401009A 2003-05-13 2004-05-11 COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS CL2004001009A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0310979.0A GB0310979D0 (en) 2003-05-13 2003-05-13 Novel compounds

Publications (1)

Publication Number Publication Date
CL2004001009A1 true CL2004001009A1 (en) 2005-03-18

Family

ID=9957979

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200401009A CL2004001009A1 (en) 2003-05-13 2004-05-11 COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS

Country Status (4)

Country Link
AR (1) AR044305A1 (en)
CL (1) CL2004001009A1 (en)
GB (1) GB0310979D0 (en)
WO (1) WO2004101589A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA06012923A (en) * 2004-05-06 2007-07-18 Glaxosmithkline Zagreb Ester linked macrolides useful for the treatment of microbial infections.
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
EP1879903A1 (en) 2005-05-10 2008-01-23 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Ether linked macrolides useful for the treatment of microbial infections
CN101906125B (en) * 2010-07-13 2012-11-14 山东大学 4''-benzimidazole-5-formacyl-ester carbazate clarithomycin derivative and midbody
CN103130848B (en) * 2013-02-22 2015-07-08 中国人民解放军第二军医大学 Macrolide antibacterial compounds, and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
GB0127349D0 (en) * 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
GB0310979D0 (en) 2003-06-18
WO2004101589A1 (en) 2004-11-25
AR044305A1 (en) 2005-09-07

Similar Documents

Publication Publication Date Title
CL2004000930A1 (en) COMPOUND DERIVED FROM DEFINED FORMULA DIHYDROQUINAZOLINE, USEFUL FOR THE TREATMENT AND / OR PROFILAXIS OF VIRAL INFECTIONS; PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMPOUND AND USE OF THE COMPOUND IN THE PREPARATION OF MEDICINES.
CL2004001012A1 (en) COMPOUNDS DERIVED FROM MACROLIDS OF 14 OR 15 MEMBERS, REPLACED IN POSITION 4 "; PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF SYSTEMIC MICROBIAL OR TOPICAL INFECTIONS
CR8642A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF METABOLIC DISORDERS
CL2008001122A1 (en) COMPOUNDS DERIVED FROM IMIDAZO [1,2,3-IJ] -1,8-NAFTIRIDIN-4,9-DIONA; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF BACTERIAL INFECTIONS.
CL2007003332A1 (en) COMPOUNDS DERIVED FROM CONDENSED HETEROCICLES; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE PREVENTION OR TREATMENT OF BACTERIAL INFECTIONS.
BRPI0922435A2 (en) "sirtuine modulatory thiazolopyridine compound, pharmaceutical composition comprising the same and its use."
CL2007002619A1 (en) COMPOUNDS DERIVED FROM 3-AZA-BICICLO [4.1.0] HEPTANO; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DEPRESSION.
CL2007002261A1 (en) COMPOUNDS DERIVED FROM IMIDAZO [1,2-B] PIRIDAZINA, QUINASA INHIBITORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OR PREVENTION OF CANCER.
CL2004001069A1 (en) COMPOUNDS DERIVED FROM 1-BENZOIL-ISOQUINOLINAS SUBSTITUTED; PREPARATION PROCEDURE, PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OR PROFILAXIS OF TYPE II DIABETES.
BRPI0508263B8 (en) 1, 2, 3,4-tetrahydro-isoquinoline derivatives, pharmaceutical composition, and use of 1, 2, 3,4-tetrahydro-isoquinoline derivative
BRPI0806531A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, AND USE OF THE COMPOUND.
ATE275393T1 (en) SOLID DISPERSIONS WITH NITRATACTIVE ACTIVE INGREDIENTS
BRPI0716495A2 (en) (R, R) - PHENOTEROL AND (R, R) - OR (R, S) - PHENOTEROL ANALOGUE, USE OF THE SAME IN THE PREPARATION OF PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL COMPOSITION UNDERSTANDING SUCH COMPOUNDS.
CL2007000161A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED 2,4-DIOXOIMIDAZOLIDINE, INHIBITORS OF KINE PROTEINS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DISEASES SUCH AS CANCER.
CL2007001630A1 (en) COMPOUNDS DERIVED FROM PIRROLIDINAMIDE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF HEPATITIS C.
CL2007001427A1 (en) 5-AMINO-3- MALEATE SALT (2 ', 3'-DI-O-ACETYL-BETA-D-RIBOFURANOSIL) -3H-TIAZOLO [4,5-D] PIRIMIDIN-2-ONA; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF A PO INFECTION
CL2004000306A1 (en) COMPOUNDS DERIVED FROM PYRIMIDINE REPLACED WITH INDANO; PROCESS FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT; PHARMACEUTICAL COMBINATION; AND ITS USE FOR THE TREATMENT OR PROFILAXIS OF AN INFECTIOUS DISEASE.
ITMI20031570A1 (en) COMPOSITION FOR DIETARY, PHARMACEUTICAL OR COSMETIC USE
CL2007003672A1 (en) COMPOUNDS DERIVED FROM HETEROARIL-PIRROLIDINIL-CETONA AND HETEROARIL-PIPERIDINIL-CETONA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DEPRESSION AND ANXIETY.
CL2007002920A1 (en) COMPOUNDS DERIVED FROM 2-AMINOCARBONYLPIRIDINE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF OCLUSIVE VASCULAR DISORDERS.
CL2007003038A1 (en) COMPOUNDS DERIVED FROM 2-PHENYL-6-AMINOCARBONIL-PYRIMIDINE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF OCLUSIVE VASCULAR DISORDERS.
CL2004001678A1 (en) COMPOUNDS DERIVED FROM OXAZOLIDINONA; PHARMACEUTICAL COMPOSITION; AND USE OF COMPOUNDS AS BACTERIAL AGENTS.
EE200300064A (en) Pharmaceutical composition for the treatment and / or prevention of C. pneumoniae infections, organic composition and their use
CL2007001542A1 (en) COMPOUNDS DERIVED FROM AMINOTIAZOLES, PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF BACTERIAL INFECTIONS.
CL2007003693A1 (en) COMPOUNDS DERIVED FROM PIRIDO [3,2-B] [1,4] THIAZINE; PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUNDS; AND ITS USE IN THE TREATMENT OF BACTERIAL INFECTIONS.